Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GAS6/TAM Axis as Therapeutic Target in Liver Diseases. | Semin Liver Dis | 2024 | 38395061 | PubTator, text mining | PubMed |
| AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells. | Cancer Lett | 2024 | 38342232 | PubTator, text mining | PubMed |
| Anti-Inflammatory Neutrophils Reprogram Macrophages toward a Pro-Healing Phenotype with Increased Efferocytosis Capacity. | Cells | 2024 | 38334600 | PubTator, text mining | PubMed |
| MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway. | J Dent Sci | 2024 | 38303867 | PubTator, text mining | PubMed |
| Nuclear translocation of Axl contributes to the malignancy of oral cancer cells. | J Dent Sci | 2024 | 38303797 | PubTator, text mining | PubMed |
| From MASH to HCC: the role of Gas6/TAM receptors. | Front Immunol | 2024 | 38298195 | PubTator, text mining | PubMed |
| Proteomic analysis of the extracellular matrix of human atherosclerotic plaques shows marked changes between plaque types. | Matrix Biol Plus | 2024 | 38292008 | PubTator, text mining | PubMed |
| Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data. | Cancer Immunol Immunother | 2024 | 38289361 | PubTator, text mining | PubMed |
| The effect of vitamin K supplementation on cardiovascular risk factors: a systematic review and meta-analysis. | J Nutr Sci | 2024 | 38282652 | PubTator, text mining | PubMed |
| RARRES2 is involved in the "lock-and-key" interactions between osteosarcoma stem cells and tumor-associated macrophages. | Sci Rep | 2024 | 38280909 | PubTator, text mining | PubMed |
| Molecular Characterization of the Recombinant Ig1 Axl Receptor Domain: An Intriguing Bait for Screening in Drug Discovery. | Molecules | 2024 | 38276597 | PubTator, text mining | PubMed |
| Identification and Validation of a Novel Anoikis-Related Gene Signature for Predicting Survival in Patients With Serous Ovarian Cancer. | World J Oncol | 2024 | 38274727 | PubTator, text mining | PubMed |
| A secretory protein neudesin regulates splenic red pulp macrophages in erythrophagocytosis and iron recycling. | Commun Biol | 2024 | 38272969 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of 2-Substituted Aniline Pyrimidine Derivatives as Potent Dual Mer/c-Met Inhibitors. | Molecules | 2024 | 38257391 | PubTator, text mining | PubMed |
| MICA+ Tumor Cell Upregulated Macrophage-Secreted MMP9 via PROS1-AXL Axis to Induce Tumor Immune Escape in Advanced Hepatocellular Carcinoma (HCC). | Cancers (Basel) | 2024 | 38254761 | PubTator, text mining | PubMed |
| Macrophage Heterogeneity and Efferocytosis: Beyond the M1/M2 Dichotomy. | Circ Res | 2024 | 38236949 | PubTator, text mining | PubMed |
| Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary disease. | BMC Med Genomics | 2024 | 38233830 | PubTator, text mining | PubMed |
| Brain clearance of protein aggregates: a close-up on astrocytes. | Mol Neurodegener | 2024 | 38229094 | PubTator, text mining | PubMed |
| Relevance Analysis of TPM2 and Clinicopathological Characteristics in Breast Cancer. | Int J Gen Med | 2024 | 38221941 | PubTator, text mining | PubMed |
| Clearance of apoptotic cells by neutrophils in inflammation and cancer. | Cell Death Discov | 2024 | 38218739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=13